Core Viewpoint - The statement from the hospital emphasizes that the online videos distorting the facts about the medical incidents are malicious and unfounded, asserting the hospital's commitment to protecting its medical staff's rights [1]. Summary by Relevant Sections Incident Overview - The hospital responded to allegations from netizens regarding a patient’s death due to "violating contraindications" and "altering medical records," claiming that the videos misrepresent the facts and create significant distress for the medical staff [1]. Patient Background - The patient involved was an elderly individual with over 20 years of hypertension and diabetes, whose family delayed seeking medical help for two days after symptoms appeared, which severely impacted the treatment outcome [1]. Medical Treatment and Outcome - The hospital reported that the patient initially improved under treatment but later experienced a critical condition due to a brain aneurysm rupture, which was deemed an unpredictable risk factor [1]. Legal and Ethical Stance - The hospital maintains that it will pursue legal action against those spreading false information and has offered to cover the costs for medical accident assessments, which were declined by the complainants [1]. Call for Rational Dispute Resolution - The hospital urges the involved parties to cease spreading misinformation and to resolve disputes through formal channels such as medical assessments and legal proceedings [1].

Company Overview - Guangdong Squirrel Hospital Management Co., Ltd. has been established with a registered capital of 20 million RMB [1] - The legal representative of the company is Li Bo, and it is wholly owned by Guangdong Squirrel Hospital Investment Co., Ltd. [1] Business Scope - The company's business scope includes enterprise headquarters management, technical services, development, consulting, communication, transfer, and promotion [1] - It also engages in investment activities using its own funds and hospital management, operating independently within the limits of its business license [1] Registration Details - The company is registered in Zhuhai, located at 868 Hong Kong-Macao Avenue, Hengqin [1] - It is classified as a limited liability company with a natural person investment or holding [1] - The business registration is valid until August 15, 2025, with no fixed term thereafter [1]

Core Points - The article discusses the innovative "face recognition medical service" launched by Henan University Huaihe Hospital, which allows patients to complete the entire medical process using only facial recognition technology, marking a new model of seamless medical service in Henan Province [3][4]. Group 1 - The "face recognition medical service" addresses common issues faced by patients, such as forgetting their medical insurance card or having a dead phone, by enabling a complete medical process from registration to payment through facial recognition [3][4]. - The service includes all steps of the medical process: patient registration, consultation, examination, medication collection, insurance settlement, hospitalization, discharge settlement, and report printing, all facilitated by facial recognition technology [3]. - The hospital has invested in 200 medical insurance terminal devices, 40 self-service machines, and 110 bedside mobile settlement terminals to support this service [3]. Group 2 - The service enhances patient experience by combining convenience and technology, effectively solving pain points for patients, especially the elderly who may struggle with smartphone usage [4]. - The implementation of this service model represents not only a technological upgrade but also a revolutionary change in service philosophy, encouraging more hospitals across the province to adopt similar practices [4].

Core Viewpoint - The successful implementation of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for a patient with gastric cancer peritoneal metastasis marks a significant advancement in treatment options for late-stage cancer patients in Zhejiang Province, providing a new international standard of care [1][6]. Group 1: Patient Case - A 60-year-old male patient, referred to as Liu, was diagnosed with gastric cancer and peritoneal metastasis, experiencing severe symptoms including significant weight loss and abdominal swelling [2][3]. - Traditional treatment options were limited for Liu due to the advanced stage of his cancer, prompting his family to seek out advanced treatment at Zhejiang Provincial Cancer Hospital [2][4]. Group 2: PIPAC Treatment Details - The PIPAC procedure involved creating a high-pressure environment in the abdominal cavity and delivering chemotherapy in aerosol form, allowing for uniform distribution of the drug to tumor sites [3][4]. - The treatment was completed in approximately one hour, and Liu experienced rapid recovery, reporting reduced abdominal swelling and improved overall well-being shortly after the procedure [3][4]. Group 3: Advantages of PIPAC - PIPAC offers significant advantages over traditional chemotherapy methods, including higher drug concentration at tumor sites and reduced systemic side effects, with the dosage being only one-tenth of that used in intravenous chemotherapy [4][5]. - This method is particularly beneficial for patients like Liu, who are physically weak and unable to tolerate aggressive treatments, and allows for repeat treatments every 4-8 weeks with real-time assessment of effectiveness [4][5]. Group 4: Institutional Impact - The successful application of PIPAC at Zhejiang Provincial Cancer Hospital represents a breakthrough in the treatment of gastric cancer, positioning the institution as a leader in the field [5][6]. - The hospital's focus on international clinical outcomes and two years of preparation led to this pioneering achievement in the province, potentially benefiting many patients suffering from peritoneal metastasis in the future [5][6].

Core Viewpoint - Corning Hospital (02120) announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company plans to repurchase 73,200 shares at a total cost of HKD 690,300 [1] - The buyback is scheduled for August 15, 2025, reflecting a strategic move to enhance shareholder value [1]

Core Viewpoint - The establishment of the vascular access center and ward at Yantai Yuhuangding Hospital marks a significant milestone in the local vascular access construction, providing high-quality medical services for dialysis patients without the need to travel to distant cities for treatment [1][6]. Group 1: Vascular Access Center and Ward - The newly established vascular access center and ward will allow local dialysis patients to receive specialized care, addressing critical issues related to vascular access that directly impact the quality of dialysis treatment [1][8]. - The vascular access ward is designed to provide a centralized treatment environment, ensuring rigorous clinical pathways and management standards for patients with vascular access issues [8]. Group 2: Medical Team and Services - The vascular access treatment team comprises experts from various fields, including vascular surgery, nephrology, and ultrasound, enabling a comprehensive approach to patient care [2]. - The center offers a range of complex procedures, including temporary and semi-permanent dialysis catheter placement, arteriovenous fistula (AVF), and artificial vascular access, all performed under real-time imaging guidance to enhance safety and effectiveness [2]. Group 3: Professional Recognition and Collaboration - The establishment of the Shandong Integrated Traditional Chinese and Western Medicine Society Vascular Access Professional Committee recognizes Yantai Yuhuangding Hospital's contributions to vascular access and positions it as a leading institution in the field [6]. - The formation of the vascular access specialty alliance aims to break regional barriers, promote resource sharing, and enhance the quality of care across the city [6]. Group 4: Patient Impact and Future Outlook - The vascular access ward has already successfully addressed the access issues for over 30 patients, demonstrating effective surgical outcomes and a commitment to patient care [8]. - The hospital's efforts in vascular access are expected to significantly improve the quality of life for kidney disease patients, providing them with reliable and accessible treatment options [8].

Group 1 - The company has a total of 38 hospitals in its medical sector, with 32 of them being rehabilitation hospitals focused on severe rehabilitation [2] - The subsidiary Ningbo Mingzhou Hospital is a tertiary Class B comprehensive hospital with over 40 departments, including dental, ophthalmology, and medical aesthetics [2]

ST中珠（SH 600568，收盘价：1.88元）8月15日晚间发布公告称，经公司总裁麻华先生提名，董事会同 意聘任刘会平先生为公司副总裁。 2024年1至12月份，ST中珠的营业收入构成为：医院收入占比55.6%，房地产项目占比25.33%，医药行 业占比8.94%，医疗器械占比4.74%，中心合作占比4.17%。 （文章来源：每日经济新闻） ...

Core Viewpoint - Shanghai has issued the "Action Plan for Comprehensive Deepening Reform of the Shanghai Carbon Market (2026-2030)", focusing on enhancing the carbon emission trading market and promoting voluntary greenhouse gas reduction initiatives [1][2]. Group 1: Key Actions - The Action Plan emphasizes three main actions: improving the carbon emission trading market, promoting voluntary greenhouse gas reduction, and enhancing innovation capabilities within the carbon market [1]. - It outlines 16 key reform tasks, including establishing a total quota management system, gradually expanding market coverage, optimizing greenhouse gas emission accounting and reporting methodologies, and increasing the proportion of paid allocation [1][2]. Group 2: Market Coverage Expansion - The plan aims to lower the entry threshold for high-energy-consuming industries, such as petrochemicals and data centers, to an annual emission of 10,000 tons of CO2 equivalent starting in 2026 [2]. - By 2028, public institutions like universities and hospitals with emissions of 10,000 tons or more will be included in the market management and gradually implement carbon emission quota management [2].

Core Viewpoint - Jiangsu University Affiliated Hospital has implemented innovative services to enhance patient experience and streamline medical processes, focusing on quality healthcare, excellent service, optimized procedures, and patient satisfaction [1][4][6]. Group 1: Service Innovations - The hospital introduced the "One-Window Service" which allows patients to complete payment, invoice printing, and appointment scheduling in just 10 minutes, significantly improving efficiency [1]. - The hospital has seen a rise in robotic-assisted surgeries, which offer smaller incisions and more precise operations, leading to reduced recovery times and lower complication risks [2]. - A new minimally invasive surgical technique for spinal surgery was introduced, showcasing the hospital's commitment to advancing medical technology and improving patient outcomes [2][3]. Group 2: Digital Transformation - The hospital has adopted a digital transformation strategy, including remote monitoring for patients, which allows for real-time blood sugar management and enhances surgical readiness [4]. - The implementation of bedside billing has increased the bedside settlement rate to over 60%, improving the discharge process for hospitalized patients [4]. - The hospital has launched an "All-Time" outpatient service, enabling patients to schedule appointments and consultations online, thus enhancing patient-doctor interactions [4]. Group 3: Patient-Centric Care - The hospital actively addresses patient concerns, such as parking difficulties, by constructing a smart parking facility that will add over 700 parking spaces [6]. - The hospital's staff has demonstrated exceptional commitment to patient care, as seen in the case of a patient with unexplained liver function damage, where coordination ensured timely treatment despite full capacity [5]. - The hospital's initiatives aim to create a comfortable and welcoming environment for patients, enhancing the overall healthcare experience [6].